Noxytiolin

Noxytiolin

SCHEMBL171505

CNC(=S)NCO

nearest known ligand 0.00

Full drug profile on Sugi Atlas →

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL942187 0.79
SCHEMBL14192214 0.78 KDM4E (0.45)
SCHEMBL4951917 0.77
SCHEMBL4570865 0.75
SCHEMBL13241884 0.73 ALDH1A1 (0.35)
SCHEMBL19296937 0.73
SCHEMBL9410886 0.73
SCHEMBL14093827 0.73
SCHEMBL9948686 0.73
SCHEMBL5448151 0.73

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 752 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250346910-A1 METHODS AND COMPOSITIONS TO PREVENT MICROBIAL INFECTION COMMENSE BIO INC (US) 2025-11-13 US claimed
WO-2025136206-A1 A NASAL DEVICE FOR USE IN DRUG DELIVERY VIA THE NASAL CAVITY NOSEOPTION AB (SE) 2025-06-26 WO claimed
US-20220346382-A1 COMPOSITION FOR TREATING AND PREVENTING BACTERIAL GROWTH ON A SUBSTRATE PETROLIAM NASIONAL BERHAD (PETRONAS) (MY) 2022-11-03 US claimed
US-20220323452-A1 METHODS AND COMPOSITIONS FOR INHIBITING GAPDH GEISTLICH PHARMA AG (CH) 2022-10-13 US claimed
US-20220288135-A1 LIVE BIOTHERAPEUTIC COMPOSITIONS AND METHODS BioPlx, Inc. (US) 2022-09-15 US claimed
EP-3996510-A2 LIVE BIOTHERAPEUTIC COMPOSITIONS AND METHODS BioPlx, Inc. (US) 2022-05-18 EP claimed
EP-3263145-B1 ANTIMICROBIAL COMPOSITIONS AND METHODS FOR LOCKING CATHETERS BECTON DICKINSON CO (US) 2021-01-20 EP claimed
WO-2021002743-A1 COMPOSITION FOR TREATING AND PREVENTING BACTERIAL GROWTH ON A SUBSTRATE PETROLIAM NASIONAL BERHAD (PETRONAS) (MY) 2021-01-07 WO claimed
WO-2020234833-A1 METHOD FOR TREATING, PREVENTING, INHIBITING OR REDUCING CYTOKINE RELEASE GEISTLICH PHARMA AG (CH) 2020-11-26 WO claimed
WO-2020234829-A1 METHODS AND COMPOSITIONS FOR INHIBITING GAPDH GEISTLICH PHARMA AG (CH) 2020-11-26 WO claimed
WO-2004108091-A2 ANTIMICROBIAL FLUSH SOLUTIONS BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) 2004-12-16 WO claimed
EP-1248625-A2 USE OF METHYLOL-CONTAINING COMPOUNDS FOR THE MANUFACTURE OF A MEDICAMENT FOR THE TREATMENT OF TUMORS RHODE ISLAND HOSPITAL (US) 2002-10-16 EP claimed
EP-1245247-A1 Biocidal locks Biolink Corporation (US) 2002-10-02 EP claimed
US-20020049200-A1 Use of a methylol-containing compound to treat tumors GEISTLICH PHARMA AG (CH) 2002-04-25 US claimed
US-6350251-B1 Biocidal locks BIOLINK CORPORATION 2002-02-26 US claimed
WO-2001039763-A2 USE OF METHYLOL-CONTAINING COMPOUNDS FOR THE MANUFACTURE OF A MEDICAMENT FOR THE TREATMENT OF TUMORS RHODE ISLAND HOSPITAL, A LIFESPAN PARTNER (US) 2001-06-07 WO claimed
CN-1294519-A Pharmaceutical composition containing a compound having an activity of promoting the absorption of an active ingredient INPHARMA SA (CH) 2001-05-09 CN claimed
EP-1073470-A1 PHARMACEUTICAL COMPOSITIONS CONTAINING COMPOUNDS WITH ACTIVITY FOR THE ENHANCEMENT OF ABSORPTION OF ACTIVE INGREDIENTS INPHARMA S.A. (CH) 2001-02-07 EP claimed
WO-2000048636-A1 PHARMACEUTICAL COMPOSITIONS CONTAINING COMPOUNDS WITH ACTIVITY FOR THE ENHANCEMENT OF ABSORPTION OF ACTIVE INGREDIENTS INPHARMA S.A. (CH) 2000-08-24 WO claimed
EP-0153180-A2 Body fluid drainage device, a pack containing the same, and a system based thereon Medical-Assist Limited (GB) 1985-08-28 EP claimed